JP2006501269A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006501269A5 JP2006501269A5 JP2004536198A JP2004536198A JP2006501269A5 JP 2006501269 A5 JP2006501269 A5 JP 2006501269A5 JP 2004536198 A JP2004536198 A JP 2004536198A JP 2004536198 A JP2004536198 A JP 2004536198A JP 2006501269 A5 JP2006501269 A5 JP 2006501269A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- retinal
- angiogenesis
- inhibitors
- effective amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41100102P | 2002-09-16 | 2002-09-16 | |
| PCT/US2003/028675 WO2004024085A2 (en) | 2002-09-16 | 2003-09-11 | Use of pde iv inhibitors to treat angiogenesis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006501269A JP2006501269A (ja) | 2006-01-12 |
| JP2006501269A5 true JP2006501269A5 (https=) | 2006-07-06 |
Family
ID=31994234
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004536198A Pending JP2006501269A (ja) | 2002-09-16 | 2003-09-11 | 血管新生を処置するためのｐｄｅｉｖインヒビターの使用 |
Country Status (14)
| Country | Link |
|---|---|
| US (3) | US20060014782A1 (https=) |
| EP (1) | EP1539174A4 (https=) |
| JP (1) | JP2006501269A (https=) |
| KR (1) | KR20050043923A (https=) |
| CN (1) | CN1681510A (https=) |
| AR (1) | AR041263A1 (https=) |
| AU (1) | AU2003267161A1 (https=) |
| BR (1) | BR0314364A (https=) |
| CA (1) | CA2497192A1 (https=) |
| MX (1) | MXPA05002146A (https=) |
| PL (1) | PL374659A1 (https=) |
| TW (1) | TW200412972A (https=) |
| WO (1) | WO2004024085A2 (https=) |
| ZA (1) | ZA200501477B (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2851247B1 (fr) | 2003-02-19 | 2007-06-29 | Exonhit Therapeutics Sa | Methodes et compositions pour le traitement de pathologies degeneratives oculaires |
| PL1755616T3 (pl) * | 2004-04-08 | 2014-10-31 | Eye Co Pty Ltd | Leczenie mineralokortykoidami retinopatii wysiękowej |
| JP2009514969A (ja) | 2005-11-09 | 2009-04-09 | コンビナトアールエックス インコーポレーティッド | 医学的状態を治療するための方法、組成物、およびキット |
| US9351947B2 (en) * | 2007-01-29 | 2016-05-31 | National Research Council Of Canada | Use of catecholamines and related compounds as anti-angiogenic agents |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2570579B1 (fr) * | 1984-09-26 | 1987-01-09 | Salomon Sa | Dispositif de fermeture et de serrage d'une chaussure de ski a ouverture arriere |
| US4975537A (en) * | 1985-10-23 | 1990-12-04 | The Upjohn Company | Δ9(11) -angiostatic steroids |
| US4771042A (en) * | 1985-11-25 | 1988-09-13 | The Upjohn Company | Inhibition of angiogenesis involving the coadministration of steroids with heparin or heparin fragments |
| GB9413975D0 (en) * | 1994-07-11 | 1994-08-31 | Fujisawa Pharmaceutical Co | New heterobicyclic derivatives |
| US5605914A (en) * | 1993-07-02 | 1997-02-25 | Celgene Corporation | Imides |
| GB9603095D0 (en) * | 1996-02-14 | 1996-04-10 | Zeneca Ltd | Quinazoline derivatives |
| ES2302350T3 (es) * | 1997-02-28 | 2008-07-01 | Nycomed Gmbh | Combinacion sinergica de inhibidores de pde y agonistas de adenilatociclasa o agonistas de guanililciclasa. |
| US5866872A (en) * | 1997-07-25 | 1999-02-02 | Hypertherm, Inc. | Plasma arc torch position control |
| DE19812515A1 (de) * | 1998-03-21 | 1999-09-23 | M & F Entw & Patentverwertungs | Lamellenschleifwerkzeug |
| HK1042896A1 (zh) * | 1998-09-29 | 2002-08-30 | 藤泽药品工业株式会社 | 吡啶并吡嗪化合物的新的盐及其结晶 |
| US6740664B2 (en) * | 1998-09-30 | 2004-05-25 | Alcon, Inc. | Methods for treating otic and ophthalmic infections |
| US6326888B1 (en) * | 1998-12-17 | 2001-12-04 | Ching-Yung Wang | Auxiliary safety warning light system for a vehicle |
| US6326388B1 (en) * | 1999-12-21 | 2001-12-04 | Celgene Corporation | Substituted 1,3,4-oxadiazoles and a method of reducing TNF-alpha level |
| AR030345A1 (es) * | 2000-08-14 | 2003-08-20 | Alcon Inc | Metodo de tratamiento de desordenes relacionados con angiogenesis |
-
2003
- 2003-09-11 KR KR1020057003469A patent/KR20050043923A/ko not_active Withdrawn
- 2003-09-11 EP EP03749635A patent/EP1539174A4/en not_active Ceased
- 2003-09-11 PL PL03374659A patent/PL374659A1/xx not_active Application Discontinuation
- 2003-09-11 US US10/527,599 patent/US20060014782A1/en not_active Abandoned
- 2003-09-11 CN CNA038215454A patent/CN1681510A/zh active Pending
- 2003-09-11 CA CA002497192A patent/CA2497192A1/en not_active Abandoned
- 2003-09-11 MX MXPA05002146A patent/MXPA05002146A/es unknown
- 2003-09-11 WO PCT/US2003/028675 patent/WO2004024085A2/en not_active Ceased
- 2003-09-11 AU AU2003267161A patent/AU2003267161A1/en not_active Abandoned
- 2003-09-11 JP JP2004536198A patent/JP2006501269A/ja active Pending
- 2003-09-11 US US10/660,152 patent/US20040053939A1/en not_active Abandoned
- 2003-09-11 BR BR0314364-3A patent/BR0314364A/pt not_active IP Right Cessation
- 2003-09-11 ZA ZA200501477A patent/ZA200501477B/en unknown
- 2003-09-15 AR ARP030103340A patent/AR041263A1/es not_active Application Discontinuation
- 2003-09-15 TW TW092125341A patent/TW200412972A/zh unknown
-
2005
- 2005-08-16 US US11/204,938 patent/US20050277648A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2003503454A5 (https=) | ||
| JP2007514005A5 (https=) | ||
| JP2004525194A5 (https=) | ||
| NO20081016L (no) | Nye 1-aryl-3-azabicyklo(3.1.0)heksaner, fremstilling og bruk for å behandle nevropsykiatriske lidelser | |
| NO2017047I1 (no) | Tofacitinib, evt. i form av et farmasøytisk akseptabelt salt, inkludert citratsalt | |
| LTC1562603I2 (lt) | Nauji vaistai, skirti lėtinių obstrukcinių plaučių ligų gydymui | |
| JP2007536277A5 (https=) | ||
| JP2007523178A5 (https=) | ||
| NO20041882L (no) | Fremgangsmater for behandling av okulare neovaskulaere sykdommer. | |
| BR0309549B1 (pt) | "artigo de fumar, e, método para controlar a velocidade de queima estática de um artigo de fumar". | |
| PL1656346T3 (pl) | 1,2,3,4-Tetrapodstawiony indol do leczenia chorób dróg oddechowych | |
| WO2002053140A3 (en) | New drug combinations of norepinehrine reuptake inhibitors and neuroleptic agents | |
| WO2007112014A3 (en) | New therapeutic combinations for the treatment of depression | |
| NO20033821D0 (no) | Anvendelse av GABA A inverse agonister i kombinasjon med nikotinreseptordelagonister, östrogen, selektive östrogenmodulatorer, ellervitamin E for behandling av kognitive forstyrrelser | |
| IL177787A0 (en) | 1-aminovyclohexane derivatives for the treatment of agitation and other behavioral disorders, especially those associated with alzheimer's disease | |
| WO2005099702A3 (en) | R(-)-11-hydroxyaporphine derivatives and uses thereof | |
| ATE468340T1 (de) | Ccr1-rezeptor-antagonisten zur behandlung u.a. demyelinisierender entzündlicher erkrankungen | |
| NO20052751D0 (no) | Oftalmisk preparat for behandling av okulaer hypertensjon. | |
| NO20055098D0 (no) | Anvendelse av 10-hydroksy-10,11-dihydrokarbamazepinderivater for behandling av affektive forstyrrelser | |
| JP2006501269A5 (https=) | ||
| ZA200104616B (en) | Diazepinoindoles for the treatment of chronic obstructive pulmonary disease. | |
| ZA200501288B (en) | Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma. | |
| JP2008519810A5 (https=) | ||
| JP2008526936A5 (https=) | ||
| JPH10237071A5 (https=) |